Novartis AG (NVS)

Novartis AG Income Statement

Financials in millions USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	51,722	46,660	43,461	43,974	49,898
Revenue Growth (YoY)	10.85%	7.36%	-1.17%	-11.87%	2.51%
Cost of Revenue	12,815	12,020	11,582	11,391	15,121
Gross Profit	38,907	34,640	31,879	32,583	34,777
Selling, General & Admin	12,564	12,489	12,193	12,756	14,197
Research & Development	9,511	9,011	9,172	8,259	8,980
Other Operating Expenses	512	498	1,301	605	1,448
Operating Expenses	22,587	21,998	22,666	21,620	24,625
Operating Income	16,320	12,642	9,213	10,963	10,152
Interest Income	568	627	377	70	91
Interest Expense	-1,006	-855	-800	-787	-869
Pretax Income	13,640	9,123	7,177	24,530	9,878
Income Tax	1,701	551	1,128	1,625	1,807
Net Income	11,941	14,850	6,955	24,021	8,072
Net Income Common	11,941	14,850	6,955	24,021	8,072
Net Income Growth	-19.59%	113.52%	-71.05%	197.58%	-31.20%
Shares Change	-2.72%	-4.78%	-2.79%	-1.57%	-0.99%
EPS (Diluted)	5.87	7.10	3.17	10.63	3.52
EPS Growth	-17.36%	123.90%	-70.16%	202.06%	-30.43%
Free Cash Flow	16,253	13,398	13,320	14,005	12,375
Free Cash Flow Per Share	7.99	6.40	6.06	6.20	5.39
Dividend Per Share	3.862	3.919	3.461	3.401	3.391
Dividend Growth	-1.44%	13.24%	1.77%	0.29%	8.68%
Gross Margin	75.22%	74.24%	73.35%	74.10%	69.70%
Operating Margin	31.55%	27.09%	21.20%	24.93%	20.35%
Profit Margin	23.09%	31.83%	16.00%	54.63%	16.18%
Free Cash Flow Margin	31.42%	28.71%	30.65%	31.85%	24.80%
Effective Tax Rate	12.47%	6.04%	15.72%	6.62%	18.29%
EBITDA	20,662	17,518	13,940	15,633	14,932
EBITDA Margin	39.95%	37.54%	32.07%	35.55%	29.93%
EBIT	16,320	12,642	9,213	10,963	10,152
EBIT Margin	31.55%	27.09%	21.20%	24.93%	20.35%

Source: S&P Capital IQ. Unknown template. Financial Sources.